Citius pharmaceuticals, inc. to present at upcoming march 2022 conferences

Cranford, n.j., march 3, 2022 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies, today announced that it will be presenting at two investor conferences in march 2022.
CTXR Ratings Summary
CTXR Quant Ranking